DOLENIO

This brand name is authorized in Cyprus, Estonia, France, Ireland, Lithuania, Malta, Netherlands, Poland, UK.

Active ingredients

The drug DOLENIO contains one active pharmaceutical ingredient (API):

1	Glucosamine UNII N08U5BOQ1K - GLUCOSAMINE
	Glucosamine is an endogenous substance, a normal constituent of the polysaccharide chains of cartilage matrix and synovial fluid glucosaminoglycans. In vitro and in vivo studies have shown glucosamine stimulates the synthesis of physiological glycosaminoglycans and proteoglycans by chondrocytes and of hyaluronic acid by synoviocytes.
	Read more about Glucosamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DOLENIO Film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AX05	Glucosamine	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AX Other antiinflammatory and antirheumatic agents, non-steroids
Discover more medicines within M01AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1366028, 1368097, 1484355, 1484366, 1484377, 1484388, 1484399
FR	Base de données publique des médicaments	60609568, 65144557
GB	Medicines & Healthcare Products Regulatory Agency	170425
LT	Valstybinė vaistų kontrolės tarnyba	1033363, 1038605, 1056818, 1056819, 1056820, 1056821, 1056822, 1056823, 1056824
MT	Medicines Authority	MA792/00101
NL	Z-Index G-Standaard, PRK	97438
PL	Rejestru Produktów Leczniczych	100213891